alexa Ganesan Kumaresan
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 

Ganesan Kumaresan

Ganesan Kumaresan
Department of Genetics School of Biological Sciences
Madurai Kamaraj University
India
Tel: +91 452 2456224
Biography

Dr.G.Kumaresan obtained B.Sc. (Zoology) and M.Sc. (Biology) from Manonmaniam Sundranar University and Madurai Kamaraj University with University first ranks in both. His doctoral research was on “Molecular Biology of the Transposon Mariner Like elements” with Prof.S.Mathavan in School of Biological Sciences, Madurai Kamaraj University. During graduate programme, many novel transposable elements were identified from silkworm. This investigation also brought a novel PCR based technique to isolate various copies of multi-copy genes from genome. Subsequent postdoctoral research trainings were with Dr.Sandy Chang and Dr.Rakesh Kumar in University of Texas M.D.Anderson Cancer Center, Houston, U.S.A. Major research focus in M.D.Anderson was to develop mouse and human cellular models to study the cancer associated characteristics of selected genes. The second postdoctoral investigation was in the area of “Cancer Genomics & Proteomics” with Dr. Patrick Tan’s Molecular Genomics group, in National Cancer Center, Singapore. Various genomics, proteomics and integrative approaches were utilized for the identification of candidate genes. By this integrative genomics and proteomics investigation, few novel tumor suppressor genes, metastasis inhibitor genes, oncogenes, drug-sensitivity determining genes and potential biomarker candidates were identified and characterized in breast and gastric cancers.

Research Interest

My group is working in the following aspects: (1) Molecular and Cellular Genomics of Cancer & Diabetes, (2) Diagnostic and Therapeutic Cancer Biomarker Discovery, and (3) Assay Development for Targeted Therapeutic Compound Screening. We mine the existing, exhaustive human genomics resources: i) to understand the molecular, cellular and genomic processes in carcinogenesis, and ii) for the development of next generation diagnostics and therapeutics. My group utilizes the human cellular models and genomics technologies to evaluate the identified therapeutic targets and to characterize the promising biomarker candidates. We are working towards the identification of powerful and realistic next generation biomarkers for the classification, prognosis and therapeutics of breast, gastric, and liver cancers. In parallel, our group is developing an array of engineered cancer cells and assays, representing different oncogenic signaling pathways, for the screening of therapeutic compounds. The developed cell lines will be valuable reagents for therapeutic compound screening in cancer drug discovery. These projects are being funded by DAE, BRNS, DST, DBT, and UGC (CEGS core). I also look for the opportunities of collaboration with interested basic, translational and clinical research teams to strengthen the resources and to achieve the goals by collective effort.

Publications

Nimesulide and Celecoxib Inhibits Multiple Oncogenic Pathways in Gastric Cancer Cells

Jayaprakash Periasamy, Muthulakshmi Muthuswami, Vignesh Ramesh, Thangaselvam Muthusamy, Amrita Jain, Chandrabose Karthikeyan, Piyush Trivedi, Rayala Suresh Kumar, Paramasamy Gunasekaran, Sun Young Rha, Partick Tan and Ganesan Kumaresan

Research Article: J Cancer Sci Ther/Vol.5.4 126-136 (2013)

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected].com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords